These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7815973)

  • 1. The yeast killer phenomenon: a hypothetical way to control Pneumocystis carinii pneumonia.
    Cailliez JC; Séguy N; Aliouat EM; Polonelli L; Camus D; Dei-Cas E
    Med Hypotheses; 1994 Sep; 43(3):167-71. PubMed ID: 7815973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a killer toxin of Pichia anomala to Pneumocystis. Perspectives in the control of pneumocystosis.
    Séguy N; Polonelli L; Dei-Cas E; Cailliez JC
    FEMS Immunol Med Microbiol; 1998 Sep; 22(1-2):145-9. PubMed ID: 9792073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of a Pichia anomala killer toxin on Pneumocystis carinii infectivity to the SCID mouse.
    Séguy N; Cailliez JC; Polonelli L; Dei-Cas E; Camus D
    Parasitol Res; 1996; 82(2):114-6. PubMed ID: 8825204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of human natural yeast killer toxin-like candidacidal antibodies on Pneumocystis carinii.
    Séguy N; Cailliez JC; Delcourt P; Conti S; Camus D; Dei-Cas E; Polonelli L
    Mol Med; 1997 Aug; 3(8):544-52. PubMed ID: 9307982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of Pneumocystis carinii to a Pichia anomala killer toxin.
    Séguy N; Aliouat EM; Dei-Cas E; Polonelli L; Camus D; Cailliez JC
    J Eukaryot Microbiol; 1994; 41(5):109S. PubMed ID: 7804202
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro decrease of rat-derived Pneumocystis carinii attachment induced by human natural yeast killer toxin-like antiidiotypic candidacidal antibodies.
    Séguy N; Polonelli L; Conti S; Dei-Cas E; Camus D; Cailliez JC
    J Eukaryot Microbiol; 1996; 43(5):27S. PubMed ID: 8822831
    [No Abstract]   [Full Text] [Related]  

  • 7. Monoclonal killer toxin-like antiidiotypic antibodies to control rat-pneumocystosis.
    Séguy N; Polonelli L; Dei-Cas E; Cailliez JC
    J Eukaryot Microbiol; 1997; 44(6):37S. PubMed ID: 9508425
    [No Abstract]   [Full Text] [Related]  

  • 8. 'Antibiobodies': antibiotic-like anti-idiotypic antibodies.
    Polonelli L; Conti S; Gerloni M; Magliani W; Castagnola M; Morace G; Chezzi C
    J Med Vet Mycol; 1991; 29(4):235-42. PubMed ID: 1941431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of anti-toxin antibodies by immunization with Pichia killer toxin-like antiidiotypic monoclonal antibodies.
    Snyder C; Seguy N; Lafitte S; Guyard C; Polonelli L; Cailliez JC; Grzych JM
    J Eukaryot Microbiol; 1999; 46(5):138S. PubMed ID: 10519290
    [No Abstract]   [Full Text] [Related]  

  • 10. Killer anti-idiotypes in the control of fungal infections.
    Magliani W; Conti S; Arseni S; Frazzi R; Salati A; Polonelli L
    Curr Opin Investig Drugs; 2001 Apr; 2(4):477-9. PubMed ID: 11566002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human, monoclonal and recombinant candidacidal, pneumocysticidal and mycobactericidal antibodies.
    Polonelli L
    Indian J Chest Dis Allied Sci; 2000; 42(4):259-63. PubMed ID: 15597672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of a Pichia anomala killer toxin on the viability of rat-derived Pneumocystis carinii.
    Jackson HC; Séguy N; Killigin EM; Dei-Cas E; Polonelli L; Cailliez JC
    J Eukaryot Microbiol; 1996; 43(5):29S. PubMed ID: 8822833
    [No Abstract]   [Full Text] [Related]  

  • 13. Pneumocystis carinii: an atypical fungal micro-organism.
    Cailliez JC; Séguy N; Denis CM; Aliouat EM; Mazars E; Polonelli L; Camus D; Dei-Cas E
    J Med Vet Mycol; 1996; 34(4):227-39. PubMed ID: 8873881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activity.
    Magliani W; Conti S; de Bernardis F; Gerloni M; Bertolotti D; Mozzoni P; Cassone A; Polonelli L
    Nat Biotechnol; 1997 Feb; 15(2):155-8. PubMed ID: 9035141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From yeast killer toxins to antibiobodies and beyond.
    Magliani W; Conti S; Travassos LR; Polonelli L
    FEMS Microbiol Lett; 2008 Nov; 288(1):1-8. PubMed ID: 18785931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro leishmanicidal activity of a monoclonal antibody mimicking a yeast killer toxin.
    Savoia D; Avanzini C; Conti S; Magliani V; Frazzi R; Polonelli L
    J Eukaryot Microbiol; 2002; 49(4):319-23. PubMed ID: 12188222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interfaces of the yeast killer phenomenon.
    Polonelli L; Conti S; Gerloni M; Magliani W; Chezzi C; Morace G
    Crit Rev Microbiol; 1991; 18(1):47-87. PubMed ID: 1854433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition by yeast killer toxin-like antibodies of oral Streptococci adhesion to tooth surfaces in an ex vivo model.
    Conti S; Magliani W; Arseni S; Frazzi R; Salati A; Ravanetti L; Polonelli L
    Mol Med; 2002 Jun; 8(6):313-7. PubMed ID: 12428062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement and Fc function are required for optimal antibody prophylaxis against Pneumocystis carinii pneumonia.
    Wells J; Haidaris CG; Wright TW; Gigliotti F
    Infect Immun; 2006 Jan; 74(1):390-3. PubMed ID: 16368994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immuno-crossreactivity of an anti-Pichia anomala killer toxin monoclonal antibody with a Williopsis saturnus var. mrakii killer toxin.
    Guyard C; Evrard P; Corbisier-Colson AM; Louvart H; Dei-Cas E; Menozzi FD; Polonelli L; Cailliez J
    Med Mycol; 2001 Oct; 39(5):395-400. PubMed ID: 12054049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.